Hormone pellets

Hormone pellets are small cylindrical implants that providers insert under the skin to release consistent doses of hormones, typically testosterone or estradiol. Patients use hormone pellets to treat hormone deficiencies, such as menopause symptoms or low testosterone (hypogonadism).

FDA does not regulate compounded hormone pellets, though practitioners prescribe them off-label. Insurers usually classify hormone pellet therapy as elective or experimental, with Aetna and Cigna explicitly excluding coverage in their 2024 policy documents.

Common CPT codes for insertion procedures include 11980 (insertion) and 11983 (removal), but reimbursement rates vary by carrier. Blue Cross Blue Shield’s published data shows less than 5% of policies nationwide cover pellet therapy for menopausal symptoms as of 2023.

Patients report average out-of-pocket costs from $300 to $700 per insertion every 3–6 months, according to Mayo Clinic and MedlinePlus statistics. Claims denials cite lack of long-term safety data and absence from standardized treatment guidelines like those from the Endocrine Society.

Some FSA and HSA plans allow reimbursement if a physician deems pellets medically necessary for clear endocrine disorders. Medicare Part B does not list hormone pellet insertion among approved treatments for hypogonadism as of June 2024, based on information from YourInsurance.info (Your Insurance Info).

Medical billing codes for associated lab monitoring typically include 84403 (testosterone) and 82670 (estradiol), which insurers may cover separately depending on diagnosis documentation.